ORA’s Chief Says Without Additional Funding, Inspections Are In Jeopardy
Executive Summary
Without additional funding from Congress, the FDA’s ORA is facing challenges in retaining and hiring new staff, which will impact inspections, said ORA’s chief Michael Rogers during a webinar.